Mesenchymal Chondrosarcoma: a Review with Emphasis on its Fusion-Driven Biology
Marc El Beaino1, Jason Roszik2, John A Livingston3
1Department of Orthopaedic Oncology, MD Anderson Cancer Center, Houston, TX, 77030, USA.
Abstract:
Mesenchymal chondrosarcoma is a rare but deadly form of chondrosarcoma that typically affects adolescents and young adults. While curative intent is possible for patients with localized disease, few options exist for patients in the unresectable/metastatic setting. Thus, it is imperative to understand the fusion-driven biology of this rare malignant neoplasm so as to lead to the future development of better therapeutics for this disease. This manuscript will briefly review the clinical and pathologic features of mesenchymal chondrosarcoma followed by an appraisal of existing data linked to the fusions, HEY1-NCOA2 and IRF2BP2-CDX1, and the associated downstream pathways.
Related Concept Videos
Nuclear Fusion
A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
What is Conservation Biology?
Biological Effects of Radiation
Tagging and Fusion Proteins


